Stock PLUR PLURI INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pluri Inc.

Equities

PLUR

US72942G2030

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
5.357 USD +9.33% Intraday chart for Pluri Inc. +2.04% +15.55%
Apr. 08 Sector Update: Health Care Stocks Decline Late Afternoon MT
Apr. 08 Sector Update: Health Care MT

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 135.3 92.97 220.2 125.9 39.79 32.98
Enterprise Value (EV) 1 105.4 69.27 176 85.51 13.57 22.71
P/E ratio -4.94 x -2.17 x -5.52 x -2.23 x -0.96 x -1.04 x
Yield - - - - - -
Capitalization / Revenue 2,706 x 1,722 x 9,573 x - 170 x 115 x
EV / Revenue 2,108 x 1,283 x 7,651 x - 58 x 79.1 x
EV / EBITDA -3.32 x -2.06 x -6.31 x -1.74 x -0.33 x -0.84 x
EV / FCF -11.8 x -4.27 x -11.1 x -6.81 x -0.62 x -1.6 x
FCF Yield -8.49% -23.4% -9.03% -14.7% -161% -62.5%
Price to Book 4.86 x 4.29 x 4.02 x 2.21 x 1.33 x 2.48 x
Nbr of stocks (in thousands) 1,386 1,872 3,113 3,973 4,043 5,140
Reference price 2 97.60 49.66 70.72 31.68 9.840 6.416
Announcement Date 9/12/18 9/12/19 9/10/20 9/13/21 9/21/22 9/12/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 0.05 0.054 0.023 - 0.234 0.287
EBITDA 1 -31.71 -33.57 -27.91 -49.25 -40.54 -26.88
EBIT 1 -33.73 -35.53 -29.48 -50.62 -41.59 -27.25
Operating Margin -67,462% -65,800% -128,156.52% - -17,774.79% -9,493.38%
Earnings before Tax (EBT) 1 -26.13 -35.31 -29.15 -49.86 -41.37 -28.89
Net income 1 -26.13 -35.31 -29.15 -49.86 -41.24 -28.32
Net margin -52,252% -65,383.33% -126,747.83% - -17,624.79% -9,867.94%
EPS 2 -19.74 -22.90 -12.82 -14.19 -10.25 -6.182
Free Cash Flow 1 -8.95 -16.21 -15.88 -12.55 -21.85 -14.19
FCF margin -17,899.75% -30,018.06% -69,065.22% - -9,338.03% -4,945.86%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/12/18 9/12/19 9/10/20 9/13/21 9/21/22 9/12/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 - - - - - 0.002
EBITDA - - - - - -
EBIT -11.44 -10.8 -10.48 -8.882 - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income 1 -11.43 -10.94 -9.865 -9.005 - -8.117
Net margin - - - - - -405,850%
EPS 2 -2.880 -2.720 -2.480 -2.240 -1.520 -1.920
Dividend per Share - - - - - -
Announcement Date 11/8/21 2/7/22 5/9/22 9/21/22 11/10/22 2/13/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 29.9 23.7 44.2 40.4 26.2 10.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -8.95 -16.2 -15.9 -12.6 -21.9 -14.2
ROE (net income / shareholders' equity) -88.9% -140% -74.8% -88.1% -92.6% -122%
ROA (Net income/ Total Assets) -55.1% -63.2% -38% -39.8% -32.2% -28.7%
Assets 1 47.4 55.86 76.62 125.4 128.2 98.84
Book Value Per Share 2 20.10 11.60 17.60 14.30 7.390 2.590
Cash Flow per Share 2 6.210 2.180 2.600 7.820 2.400 1.040
Capex 1 0.34 0.24 0.27 0.37 0.28 0.26
Capex / Sales 684% 442.59% 1,173.91% - 119.66% 91.29%
Announcement Date 9/12/18 9/12/19 9/10/20 9/13/21 9/21/22 9/12/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PLURI INC. Stock Pluri Inc.
+15.55% 27.91M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PLUR Stock
  4. Financials Pluri Inc.